Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2012
12/20/2012WO2012172346A2 Treating respiratory conditions
12/20/2012WO2012172345A2 Treating conditions associated with allergy
12/20/2012WO2012172344A2 Treating conditions associated with sepsis
12/20/2012WO2012172343A2 Treating primary sclerosing cholangitis
12/20/2012WO2012172342A2 Treating multiple sclerosis
12/20/2012WO2012172340A2 Treating mental disorders
12/20/2012WO2012172339A2 Treating inflammatory arthritis
12/20/2012WO2012172337A2 Treating cardiovascular disease
12/20/2012WO2012172336A2 Treating inflammatory skin diseases
12/20/2012WO2012172333A1 Apparatus and method for fluid measurement
12/20/2012WO2012172232A1 Device and method for immunoassays
12/20/2012WO2012172097A1 Method for determining a plasma volume variation and devices for implementing the method
12/20/2012WO2012172095A1 Method for generating cyan fluorescent proteins which have a reduced ph sensitivity
12/20/2012WO2012172018A1 Use of luminescent nanosystems for authenticating security documents
12/20/2012WO2012172013A1 Diagnostic marker for acute coronary syndrome
12/20/2012WO2012172011A1 Method for analysis of exhaled air
12/20/2012WO2012172005A1 Biomarkers for autoimmune liver diseases and uses thereof
12/20/2012WO2012172004A1 Biomarkers for autoimmune liver diseases and uses thereof
12/20/2012WO2012172002A1 Luminescent nanosystems
12/20/2012WO2012171878A1 Method for ascertaining the ischemic level of a patient with suspected stroke
12/20/2012WO2012171783A1 Device and method for determining the carbon dioxide content of air
12/20/2012WO2012171560A1 Plasma or serum separator
12/20/2012WO2012171112A1 Isolated embryonic stem cells that express lineage markers and associated methods
12/20/2012WO2012149269A3 Determination of cd and md variations from scanning measurements of a sheet of material
12/20/2012WO2012148960A3 Systems and methods for detecting and quantifying a sequence of nucleotides
12/20/2012WO2012146778A3 Method for indicating a renal disease in a patient by determining at least one protein in isolated hdl
12/20/2012WO2012145574A3 Methods, compositions and systems for sample deposition
12/20/2012WO2012145270A3 Luminescent polymer cyclic amplification
12/20/2012WO2012142568A3 Remote transmission of electromagnetic signals inducing nanostructures amplifiable into a specific dna sequence
12/20/2012WO2012141605A4 Systems and method for detection and quantitation of analytes using impedance analysis
12/20/2012WO2012140148A3 Junction plakoglobin for diagnosis of cardiovascular diseases
12/20/2012WO2012138740A3 Risk analysis for disease development
12/20/2012WO2012135340A3 Compositions and methods for diagnosing cancer
12/20/2012WO2012125770A3 Controlled fabrication of nanopores in nanometric solid state materials
12/20/2012WO2012115493A3 Biomarker for cancer, and cancer diagnosis using same
12/20/2012WO2012113906A3 Solid support and method of enhancing the recovery of biological material therefrom
12/20/2012WO2012110833A3 Fluorescence modulators
12/20/2012WO2012108675A3 Pna aptamer able to isolate a metal
12/20/2012WO2012108669A3 Uranyl ion specific dna aptamer
12/20/2012WO2012108651A3 Biochip including conductive particle and device for detecting target antigen comprising the same
12/20/2012WO2012102527A3 Novel use of regulatory t cell-specific surface protein lrig-1
12/20/2012WO2012083020A3 Antibody-linked immuno-sedimentation agent and method of isolating a target from a sample using same
12/20/2012WO2012071504A3 Process for detecting ischemic injury
12/20/2012WO2011156468A8 A method of predicting clinical outcomes for melanoma patients using circulating melanoma cells in blood
12/20/2012WO2005046607A3 Combinations for the treatment of proliferative diseases
12/20/2012US20120324593 Lysyl Oxidase-Like 1 (LOXL1) and Elastogenesis
12/20/2012US20120323215 System and method for administering medicaments on the basis of urine values
12/20/2012US20120322830 Cyclourea Compounds as Calcium Channel Blockers
12/20/2012US20120322792 Method and Compositions for Treating Cancer and Related Methods
12/20/2012US20120322740 Mu opioid receptor agonist analogs of the endomorphins
12/20/2012US20120322717 Compounds and assays for controlling Wnt activity
12/20/2012US20120322688 Testing lumenectomy samples for markers of non-vascular diseases
12/20/2012US20120322687 Methods of predicting high grade gliomas using senescence associated genes
12/20/2012US20120322685 Device for collecting and analyzing migratory tumor cells
12/20/2012US20120322684 G-csf protein having a deletion of an amino acid sequence corresponding to exon 3 for use as a diagnostic cancer marker
12/20/2012US20120322683 Enzymatic signal generation and detection of binding complexes in stationary fluidic chip
12/20/2012US20120322674 Detecting cyp24 expression level as a marker for predisposition to cancer
12/20/2012US20120322668 Assessment of solid tumor burden
12/20/2012US20120322165 Highly sensitive immunochromatography method and immunochromatography kit
12/20/2012US20120322163 Immunoassay for assessing related analytes of different origin
12/20/2012US20120322091 Pharmacologic method of lowering cholesterol production
12/20/2012US20120322090 Solid phase-bound elastase-binding assay for the measurement of alpha1-antitrypsin activity
12/20/2012US20120322089 Sensitive and generic antibodies and multiple applications
12/20/2012US20120322088 Methods for the diagnosis, risk assessment, and monitoring of autism spectrum disorders
12/20/2012US20120322087 Method for examining acute renal disorder
12/20/2012US20120322085 Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent
12/20/2012US20120322083 Antibody binding to abca1 polypeptide
12/20/2012US20120322082 Biomarker for amyotrophic lateral sclerosis and diagnostic kit and method used thereof
12/20/2012US20120322080 Measurement of PKA for Cancer Detection
12/20/2012US20120322079 Method for testing or screening protein synthesis inhibitors
12/20/2012US20120322076 Microchamber electrochemical cell having a nanoslot
12/20/2012US20120322075 Lung Tumor Markers and Methods of Use Thereof
12/20/2012US20120322074 Prostate Tumor Markers and Methods of Use Thereof
12/20/2012US20120322073 Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor
12/20/2012US20120322071 Method for quantitative measurement of gene expression for indentifying individuals at risk for bronchogenic carcinoma
12/20/2012US20120322070 Cryogenic biopsy system and method
12/20/2012US20120322065 Methods for Use with Nanoreactors
12/20/2012US20120322062 Methods And Compositions For Detection Of Cowden Syndrome (CS) and CS-Like Syndrome
12/20/2012US20120322061 Macromolecular compound for detecting target material and method of detecting target material by using the same
12/20/2012US20120322060 Diagnosis and monitoring treatment of psychiatric diseases with spadin and related methods
12/20/2012US20120322059 Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and method of detection
12/20/2012US20120322056 Rna-exit-channel: target and method for inhibition of bacterial rna polymerase
12/20/2012US20120322055 Molecular Dispensers
12/20/2012US20120322048 Materials and Methods for Assessing and Mapping Microbes and Microbial Biofilms on Wounds
12/20/2012US20120322047 Apparatus And Method For Cell Exploitation
12/20/2012US20120321763 Doneness indicator for cooking meats
12/20/2012US20120321759 Characterization of food materials by optomagnetic fingerprinting
12/20/2012US20120321724 Method of Measuring and Monitoring In Vivo Nitrite Levels
12/20/2012US20120321705 Lineage Restricted Glial Precursors from the Central Nervous System
12/20/2012US20120321659 Hbv core antigen particles with multiple immunogenic components attached via peptide ligands
12/20/2012US20120321657 Group a streptococcus multivalent vaccine
12/20/2012US20120321653 Novel chimeric polynucleotides and polypeptides enabling the secretion of a polypeptide of interest in combination with exosomes and uses thereof
12/20/2012US20120321651 Anti-IGE Vaccines
12/20/2012US20120321648 Use of islet glucose-6-phosphatase related protein as a diagnostic tool and therapeutic target for autoimmune diabetes
12/20/2012US20120321644 Methods for diagnosing mood disorders
12/20/2012US20120321639 Methods and compositions for the inhibition of stat5 in prostate cancer cells
12/20/2012US20120321636 Antibodies specific for sclerostin and methods for increasing bone mineralization
12/20/2012US20120321635 Composition Containing Inhibitors of the Expression or Activity of SH3RF2 for Preventing or Treating Cancer
12/20/2012US20120321634 Estrogen receptors and methods of use
12/20/2012US20120321633 Anti-human epo receptor antibodies and methods of use
1 ... 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 ... 3937